With a discovery that could rewrite the immunology textbooks, an international group of scientists, including the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) identified a new type of antigen-presenting immune cell. These cells, that are part of an expanding family of dendritic cells, play a crucial role presenting antigens to other immune cells during respiratory virus infections, and could explain how convalescent plasma helps to boost immune responses in virus-infected patients.
Inflammation and immunity
When our body faces an infection, it responds with inflammation and fever. This is a sign that the immune system does its work, and leads to the activation of many cells, like soldiers in an army. Dendritic cells (DCs) are the generals of that army. They can precisely activate and instruct the soldiers to kill infected cells by presenting antigens derived from the ‘invaders’ to cells of the immune system.
There are several types of DCs that perform antigen-presenting functions in the body. A first type of conventional DCs continuously scan the body for dangerous invaders, even when there is no infection. When there is inflammation triggered by infection, another subset of DCs emerges from inflammatory monocytes. Because monocyte-derived DCs are easily prepared in vitro from monocytes isolated form human blood, it was always assumed these cells were very important antigen-presenting cells. Clinical trials using monocyte-derived DCs in cancer therapy have however been
A study by the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) and international colleagues, shows that monocyte-derived DCs are poor antigen-presenting cells, but have wrongly been assumed to have these functions because of a case of mistaken identity.
The scientists studied mice with a viral respiratory infection (pneumonia virus of mice and influenza virus) with single-cell technologies. This single-cell resolution allowed them to finely separate the monocyte-derived cells from other DCs during their response to the infection. They found that monocyte-derived DCs do exist, but actually do not present antigens. The reason for all the confusion in the past is that a look-alike new DC emerges – called inflammatory type 2 conventional DC, or inf-cDC2 – that combines some of the best characteristics of monocytes, macrophages, and conventional DCs, to induce the best form of immunity.
Bart Lambrecht: “This was a big surprise for us. We’ve all been taught that monocyte-derived cells are excellent antigen presenting cells, certainly when there’s inflammation. Now, we show that it’s actually a new hybrid DC type that’s doing all the work. This really changes what we know about the immune system and is very important knowledge for understanding respiratory viral infections and other inflammatory diseases.”
Martin Guilliams: “It took a massive team effort but the strength of single-cell sequencing has finally cracked the complex DC code. Many contradicting findings from the last two decades now make much more sense. This also opens tremendous therapeutic opportunities, since vaccination strategies can now be designed to trigger formation of inf-cDC2s and thus generate a stronger antiviral immune response.”
Charlotte Scott: “Through the use of single cell technologies we have been able to align all the findings from the past few years and identify the distinct cell types involved. Moving forward it will be very interesting to see under what other inflammatory conditions these inf-cDC2s are generated and how they can potentially be targeted therapeutically.”
Convalescent plasma and COVID-19
The findings of the researchers also have a direct relevance for the current COVID-19 pandemic, caused by another respiratory virus. An emergency treatment that is currently being explored is the use of convalescent plasma, or the blood plasma of recovered patients.
Cedric Bosteels, lead author of the new paper: “One of the unique features of the new DCs is that they express functional Fc receptors for antibodies that are found in the plasma of patients who have recovered from COVID-19”
This study is the first to show that one of the mechanisms through which convalescent plasma and the virus-specific antibodies in it work, is via boosting of inf-cDC2. Since boosted DCs induce a much stronger immune response, this study reveals a new target for therapeutic intervention for viral infections and other inflammatory diseases.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Can summer sun kill coronavirus? Study claims midday UV rays can 'inactivate' 90% of coronavirus - but experts say it will make 'no difference to the infection rate'on June 23, 2020 at 10:52 am
Two retired US government scientists tested the virus's survival against UV rays, but two outside experts say that sun may 'clean up' spare virus in the air but will not stop transmissions.
- Risk of Chronic Upper Respiratory Infection (image)on June 23, 2020 at 9:57 am
The risk of chronic upper respiratory infection appears to be significantly greater for cats in institutional hoarding settings, as shown by this individual rescued by the Toronto Humane Society.
- Homeless patients with respiratory infections more likely to be treated with ventilators than non-homelesson June 22, 2020 at 8:10 am
Researchers from UCLA, Harvard Medical School, and the University of Tokyo found that during a recent six-year period, homeless people in New York state were more likely to hospitalized and treated ...
- WHOOP Leverages Respiratory Rate Technology to Predict COVID-19on June 22, 2020 at 7:45 am
WHOOP, the human performance company, has leveraged its respiratory rate technology to predict COVID-19 in a new study conducted ...
- New article clarifies details of COVID-19 respiratory transmissionon June 22, 2020 at 7:40 am
In a new article, scientists provide an exhaustive, evidence-based review of how COVID-19 droplets from infected patients spread through the air and describe how health care professionals can protect ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Antigen-presenting immune cell
- Inside the Coronaviruson June 23, 2020 at 8:07 am
The adaptive immune system gears up for a greater response ... 2 virus presents various molecules called antigens that belong to the real virus. Antigen-presenting cells grab them and provide them to ...
- New Preclinical Data Demonstrates Immune-Enhancing Effects of Triple I/O Combination Therapy with BeyondSpring’s Plinabulinon June 23, 2020 at 5:00 am
The Triple I/O Combination of Plinabulin, Anti-PD-1 and Radiation Achieved a 100 Percent Complete Response in Anti-PD-1 Non-responsive Animal Model Triple I/O Combination to Be Administered to ...
- T cells need to ‘relax’ to work beston June 17, 2020 at 9:10 am
T cell "relaxation" may helpvexplain the cascading sequence by which invaders prompt the immune system to act.
- Relaxation time of T cells crucial to immune responseon June 16, 2020 at 4:15 pm
on the surface of antigen-presenting cells. At a high enough concentration, the bound complexes trigger the immune cascade. The mathematical model aligned with experimental results that suggest T cell ...
- 'Relaxed' T cells critical to immune responseon June 16, 2020 at 1:19 pm
Like finding that needle in the haystack every time, your T cells manage what seems like an improbable task: Quickly finding a few invaders among the many imposters in your body to trigger its immune ...